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ABSTRACT
Lac repressor (LacR) Is a helix-turn-helix motif
sequence-specific DNA binding protein. Based on
proton NMR spectroscopic investigations, Kaptein and
co-workers have proposed that the hellx-turn-helix
motif of LacR binds to DNA in an orientation opposite
to that of the helix-turn-helix motifs of X repressor,
X cro, 434 repressor, 434 cro, and CAP [Boelens, R.,
Scheek, R., van Boom, J. and Kaptein, R., J. Mol. Biol.
193, 1987, 213-216]. In the present work, we have
determined the orientation of the hellx-turn-helix motif
of LacR in the LacR-DNA complex by the affinity
cleaving method. The DNA cleaving moiety EDTA-Fe
was attached to the N-terminus of a 56-residue
synthetic protein corresponding to the DNA binding
domain of LacR. We have formed the complex between
the modified protein and the left DNA half site for LacR.
The locations of the resulting DNA cleavage positions
relative to the left DNA half site provide strong support
for the proposal of Kaptein and co-workers.
INTRODUCTION
Escherichia coli Lac repressor (LacR) is a transcriptional
regulatory protein; LacR functions by binding, in the absence
of the inducer molecules allolactose or isopropyl-/3-D-
thiogalactoside, to a specific DNA site, lac operator, located
adjacent to the lac promoter (reviewed in ref. 1). LacR and its
specific DNA site have been subjected to extensive structural,
biophysical, biochemical, and genetic analyses (2—5). LacR is
a tetramer of four chemically identical subunits, each consisting
of 360 amino acids. The 56 N-terminal amino acids constitute
the DNA binding domain of LacR. The DNA binding domain
of LacR can be cleaved proteolytically from the remainder of
the molecule to yield a 56-residue fragment that folds
independently and that binds to the specific DNA site (6-8) .
The three-dimensional structure of the DNA binding domain of
LacR has been determined by proton NMR spectroscopic
investigations (9). The consensus DNA site for LacR is 5'-AA-
TTGTGAGCGCTCACAATT-3' (10,11); the site is 20 base pairs
in length and exhibits perfect two-fold sequence symmetry. The
left DNA half site for LacR is 5'-AATTGTGAGC-3'.
LacR is a member of a class of at least 150 sequence-specific
DNA binding proteins—prokaryotic and eukaryotic—that utilize
a highly conserved a-helix-turn-a-helix motif to mediate
interaction with DNA (12-14; reviewed in refs. 15,16). Five
other members of this class (i.e., X repressor [17], X cro [18],
434 repressor [19], 434 cro [20], and CAP [21]) have been
documented to interact with DNA as illustrated schematically in
Figure 1A. In the case of LacR, amino acids 5 through 25
constitute the helix-turn-helix motif.
Two models have been proposed for the structure of the LacR-
DNA complex. The models differ in the orientation of the helix-
turn-helix motif of each subunit with respect to the DNA site.
Based on amino acid sequence and three-dimensional structural
homology considerations, Matthews and co-workers (12; see also
ref. 22) proposed that the helix-tum-helix monf-DNA orientation
in the case of LacR is similar or identical to the orientation
documented in the cases of X repressor (17), X cro (18), 434
repressor (19), 434 cro (20), and CAP (21) (Figure 1A). In this
model, the N-terminus of the helix-tum-helix motif of LacR is
near to base pair 4 of the DNA half site, and the C-terminus
of the helix -turn-helix motif of LacR is near to base pair 10 of
the DNA half site. In contrast, based on proton NMR
spectroscopic investigations, Kaptein and co-workers (23-26)
have proposed that the helix-tum-helix motif-DNA orientation
in the case of LacR is opposite—180° different—from the
orientation in the cases of the other proteins (Figure IB). In this
model, the N-terminus of the helix-tum-helix motif of LacR is
near to base pair 10 of the DNA half site, and the C-terminus
of the helix-tum-helix motif of LacR is near to base pair 4 of
the DNA half site.
Recent genetic (27) and photccrosslinking (28) results provide
strong support for the model of Kaptein and co-workers (23 -26;
Figure IB). Genetic results suggesting that amino acid 18 of LacR
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contacts base pair 7 of the DNA half site (22,29,30) are consistent
both with the model of Matthews and co-workers (12) and with
the model of Kaptein and co-workers (23—26). Genetic results
suggesting that amino acid 22 of LacR contacts base pair 5 of
the DNA half site (27) are consistent only with the model of
Kaptein and co-workers (23-26). Photocrosslinking results
suggest that amino acid 17 of LacR is close to base pair 8 of
the DNA half site, and that amino acid 29 of LacR is close to
base pairs 3 and 4 of the DNA half site (28). In the present work,
we have obtained additional strong support for the model of
Kaptein and co-workers (23—26).
The DNA cleaving moiety, EDTA-Fe, can be incorporated
at discrete amino acid residues in a protein, thus allowing the
positions of these residues in a DNA complex to be mapped to
nucleotide resolution by high resolution gel electrophoresis
(31 —37). We have used the affinity cleaving method to determine
the location of the N-terminus of LacR within the LacR-DNA
complex. We have attached EDTA • Fe to the N-terminus of the
56-residue LacR DNA binding domain peptide LacR(l —56), to
construct [(EDTA-Fe)-7-aminobutyryl]LacR(l—56) (Figure 2).
After formation of the [(EDTA • Fe)-7-aminobutyryl] LacR
(1 — 56)-DNA complex, DNA cleavage is initiated by addition
of the reducing agent sodium ascorbate. We have found that DNA
cleavage occurs just beyond base pair 10 of the DNA half site.
MATERIALS AND METHODS
[ (EDTA • Fe)-7-aminobutyryl]LacR(l - 56)
Manual peptide synthesis was carried out by solid phase
techniques in 20 ml vessels fitted with coarse glass frits, using
synthetic protocols developed at the California Institute of
Technology (38-40). Fully-protected, resin-bound LacR(l -56)
was synthesized on benzhydrylamine resin using t-Boc protected
amino acids, y-aminobutyric acid was incorporated at the
deprotected N-terminus of otherwise-protected resin-bound
LacR(l —56) using t-butoxycarbonyl-7-aminobutyric acid. EDTA
was incorporated at the deprotected N-terminus of otherwise
protected resin-bound [7-aminobutyric acid]LacR( 1—56) using
tricyclohexyl-EDTA (41) and standard coupling chemistry.
[EDTA-7-aminobutyryl]LacR(l —56) was cleaved from the resin
and deprotected using anhydrous hydrofluoric acid in the presence
of p-cresol and p-thiocresol radical scavengers.
[EDTA-7-aminobutyryl]LacR(l —56) was purified by reverse-
phase HPLC on a semipreparative C8 column (Vydac) with a
linear gradient of acetonitrile-water with 0.1% trifluoroacetic acid
(flow rate, 3ml/min, 0 to 60% acetonitrile over 240 min). The
peptide was homogeneous by the criteria of HPLC, amino acid
analysis, and amino acid sequencing. Mass spectrometric
analysis: calculated, 6584.5; found 6587 ±13. [EDTA-7-
aminobutyryl]LacR(l -56) was stored dry at -70°C in 5 nmol
aliquots (e275=5620 for four Tyr residues). [(EDTA • Fe)-7-
aminobutyryl]LacR(l-56) was prepared by incubation of
[EDTA-7-aminobutyryl]LacR(l—56) with aqueous ferrous
ammonium sulfate in a 1:1 molar mixture (30 min, 25°C).
DNA substrate
Plasmid pJS18H is a derivative of pUC18 (41) having a 66 base
pair Xmal-Pstl insert containing the left DNA half site for LacR,
5'-AATTGTGAGC-3'. Plasmid pJS18H was linearized by
digestion with EcoRI. Linearized plasmid pJS18H was 3'-end-
labeled with [a32P]-dATP and DNA polymerase I Klenow
B
Figure 1. The two models for the structure of the LacR-DNA complex. Heavy
filled circles indicate the approximate position of the N-terminus of each subunit.
A. Model of Matthews and co-workers (12; see also ref. 22); this model is based
on the experimentally documented models for the structures of the protein-DNA
complexes of Xrepressor (17), Xcro(18), 434repressor (19), 434cro(20), and
CAP (21). The helix-tum-helix motifs of two subunits of the LacR tetramer are
proposed to make equivalent, two-fold related contacts with adjacent DNA major
grooves. The second or-helix of each helix-turn-helix motif (the 'recognition a-
helix') is proposed to interact within the major groove. B. Model of Kaptein and
co-workers (23—26); the orientation of the helix-tum-helix motif of each subunit
is inverted relative to the orientation in A.
fragment (42). Linearized plasmid pJS18H was 5'-end-labeled
by dephosphorylation using calf intestinal alkaline phosphatase,
followed by phosphorylation using [732P]-ATP and T4
polynucleotide kinase (42). Labeled linearized plasmid pJS18H
was digested with Ndel, and the resulting labeled 317 base pair
DNA fragment was isolated using non-denaturing polyacrylamide
gel electrophoresis.
DNA cleavage experiments
Reaction mixtures (10/xl) contained 32P end-labeled DNA frag-
ment (20,000 cpm), 50 /tM [(EDTA • Fe)-7-aminobutyryl]LacR
(1 —56), 1 mM sodium ascorbate, 50 mM tris-acetate, pH 7.0,
20 mM NaCl, 0.1 mg/ml tRNA (Sigma Chemical, Type XX),
and 0.5 mg/ml bovine serum albumin. All components except
sodium ascorbate were incubated for 30 min at 37 °C. Reactions
were initiated by the addition of sodium ascorbate (1 mM), and
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Figure 2. A. The sequence of amino acids 1 to 56 of LacR. B. Synthetic protein
[EDTA-7-aminobutyryl]LacR(l -56).
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Figure 3. left panel Autoradiogram of a high-resohinon denaturing polyacrylamide
gel. Lanes 1 —4 present data for DNA 3'-end-labeled on the right DNA strand.
Lanes 5 - 8 present data for DNA 5'-cnd-labeled on the left DNA strand. Lanes
1 and 5, intact DNA; lanes 2 and 6, chemical-sequencing A reaction (46); lanes
3 and 7, chemical sequencing G reaction (42); lanes 4 and 8, [(EDTA • Fe)-7-
aminobutyryl]LacR(l -56) affinity cleavage, right panel [(EDTA-Fe)-7-amino-
butyryl]LacR(l -56) affinity cleavage. The figure illustrates the 10 base pair left
DNA half site for LacR. Arrows indicate nucleotides at which DNA cleavage
above-background is observed; length of the arrows indicates the relative extent
of cleavage.
were allowed to proceed for 30 min at 22 °C. Reactions were
terminated by desalting using Sephadex G-50 spin columns.
Reaction products were analyzed by denaturing electrophoresis
on 8% polyacrylamide gels (1:20 crosslink, 7M urea) (43). After
electrophoresis, gels were dried and autoradiographed. Auto-
radiograms were analyzed by laser densitometry.
Figure 4. Model for the structure of the complex between [(EDTA • Fe)-7-
aminobutyryl]LacR(l -56) and the left DNA half site. a-Helices are illustrated
as cylinders with arrows pointing from the N-terminus to the C-terminus. Filled
circles indicate nucleotides at which DNA cleavage is observed; the diameter
of the circles indicates the relative extent of cleavage. The model is in agreement
with the model of Kaptein and co-workers (23-26; Figure IB).
RESULTS AND DISCUSSION
In the DNA cleavage experiments reported here, we have invest-
igated the left DNA half site for LacR, rather than the full, two-
fold symmetric consensus DNA site for LacR. A single cleavage
pattern resulting from one bound EDTA-Fe moiety would result
in the least ambiguous data with regard to orientation assignment.
Parallel DNA cleavage experiments with the full two-fold
symmetric consensus DNA site for LacR yield consistent results.
DNA cleavage experiments were performed with [(EDTA • Fe)-
7-aminobutyryl]LacR(l -56) and a 317 base pair DNA fragment
containing the left DNA half site in the presence of the reducing
agent sodium ascorbate. DNA cleavage significantly above-
background level was observed at five adjacent nucleotides on
one DNA strand and at four adjacent nucleotides on the opposite
DNA strand (Figure 3). These nucleotide positions are located
immediately beyond base pair 10 of the left DNA half site: i.e.,
at base pairs 11, 12, 13, 14, 15 and 16. These results establish
that the EDTA • Fe moiety of [(EDTA • Fe)-7-aminobutyryl]LacR
(1 -56) is near to base pairs 11 to 16 of the left DNA half site
in the [(EDTA-Fe)-7-aminobutyryl]LacR(l -56)-DNA complex.
These results cannot easily be reconciled with the model of
Matthews and co-workers (12; see also ref. 22, Figure 1A). In
contrast, these results are in good agreement with the model of
Kaptein and co-workers (23-26; Figures IB,4).
The five adjacent nucleotides at which above-background DNA
cleavage was observed on one DNA strand are shifted
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approximately one nucleotide in the 3' direction relative to the
four adjacent nucleotides at which above-background DNA
cleavage was observed on the opposite DNA strand (Figure 3).
This DNA cleavage pattern is diagnostic of DNA cleavage by
EDTAFe located in or near the DNA minor groove (31—37).
Therefore, this result suggests that the EDTA-Fe moiety of
[(EDTAFe)-7-aminobutyryl]LacR(l-56) is near the DNA
minor groove in the [(EDTA • Fe)-7-aminobutyryl]LacR(l —56)-
DNA complex (Figure 4). This is in agreement with the model
of Kaptein and co-workers. We conclude, as proposed by
Kaptein, that the helix-turn-helix motif of LacR binds to DNA
in an orientation opposite to that of the helix-turn-helix motifs
of X repressor, X cro, 434 repressor, 434 cro, and CAP.
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